Kun Run Biotechnology Inc (KURU.PK)

KURU.PK on OTC Markets Group

0.25USD
12 Jun 2014
Price Change (% chg)

$-0.25 (-50.00%)
Prev Close
$0.50
Open
$0.25
Day's High
$0.25
Day's Low
$0.25
Volume
2,000
Avg. Vol
33
52-wk High
$1.00
52-wk Low
$0.20

KURU.PK

Chart for KURU.PK

About

Kun Run Biotechnology, Inc. is engaged, through Hainan Zhonghe Pharmaceutical Co., Ltd. (Zhonghe), its China-based indirect subsidiary, in the development, manufacture, marketing and sale of prescription polypeptide drugs. The Company’s principal products are prescription polypeptide drugs used to treat immune system malfunction... (more)
No analyst recommendations are available for KURU.PK.

Overall

Beta: --
Market Cap (Mil.): $6.25
Shares Outstanding (Mil.): 25.00
Dividend: --
Yield (%): --

Financials

  KURU.PK Industry Sector
P/E (TTM): 1.50 32.84 33.70
EPS (TTM): 0.17 -- --
ROI: 15.08 18.11 17.35
ROE: 15.27 18.82 18.21
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: MarketLine (a Datamonitor Company)
$50.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks